|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects 显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 2 | Pharmacokinetics of moxifloxacin, a novel 8- methoxy- quinolone, in patients with renal dysfunction显示文摘 | STASS H KUBITZA D HALABI A et ol | 2002 | Br J Clin Pharmacol2002，53，3： | 1 |
| 3 | Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study显示文摘 | Stass H Nagelschmitz J Willmann S | 2013 | Clin Drug Investig2013，33，6： | 1 |
| 4 | Pharmacokinetics, safety,and tolerbility of ascending single doses of Moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemothe1998，42，8： | 1 |
| 5 | Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis:aphase I,randomized,dose-escalation study显示文摘 | Stass H Weimann B Nagelschmitz J | 2013 | Clin Ther2013，35，10： | 1 |
| 6 | Pharmacokinetics, safety, and tolerability of ascending singledoses of moxifloxacin, a new 8-rnethoxyquinolone, administered to healthy subjects显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | 42(8): 2060-20651998，42，8： | 1 |
| 7 | Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man显示文摘 | Stass H Kubitza D | 1999 | J Antimicrob Chemother1999，43，： | 1 |
| 8 | Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man 显示文摘 | Stass H Kubitza 13 | 1999 | J Antimicrob Chemoth1999，43，： | 1 |
| 9 | Determination of minimal sampling time points for reliable pharmacokinetic evaluation of recombinant factor Ⅷ-an exploratory population pharmacokinetic analysis in paediatric patients suffering from severe haemophilia显示文摘 | Stass H | 2006 | Haemophilia2006，12，4： | 1 |
| 10 | Influence of orally administered moxifloxacin on the steady-state pharmacokinetics (PK) of digoxin (D) in healthy volunteers 显示文摘 | Stass H Frey R Kubitaz D | 1999 | J Antimicrob Chemother1999，44，： | 1 |
| 11 | Pharmacokinetics, safety and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects显示文摘 | Stass H Dahloff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，： | 1 |
| 12 | Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man显示文摘 | Stass H Kubitza D | 1999 | J Antimicrob Chemother1999，443，： | 1 |
| 13 | Pharmacokinetics,Safety,and Tolerability of Ascending Single Doses of Moxifloxacin,a New 8-Methoxy Quinolone,Administered to Healthy Subjects显示文摘 | Stass H Dalhoff A Kubitua D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 14 | Pharmacokinetics,Safety,and Tolerability of Ascending Single Doses of Moxifloxacin,a New 8-Methoxy Quinolone,Administered to Healthy Subjects显示文摘 | Stass H Dalhof A Kubitza D et a1 | 1998 | Antimic Agents Chemother1998，42，8： | 1 |
| 15 | Pharmacokinetics,safety andtolerability of moxifloxacin,a novel 8-met hoxyfluoroquinolone,after repeated oral administ ration显示文摘 | Stass H Kubitza D Schuhly U | 2001 | Clin Pharmacokinet2001，40，11： | 1 |
| 16 | Pharmacokinetics,safety,and tolerability of ascending single doses of moxifloxacin,a new 8-methoxy guinolone,administered to healthy subjects显示文摘 | Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，： | 1 |
| 17 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-metnoxy quinolone, administered to healthy subjects 显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 18 | Bone marrow necrosis in children with malignant disease显示文摘 | Ching H Stass S Green A | 1985 | Cancer1985，56，： | 1 |
| 19 | Pharmacokinefics, Safety and Tolerability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, after Repeated Oral Administration 显示文摘 | Stass H Kubitza D Schuhly U | 2001 | Clinical Pharmacokinetics2001，40，1： | 1 |
| 20 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects显示文摘 | STASS H DALHOFF A KUBITZA D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员